Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Myasthenia Gravis Treatment Market, by Treatment, 2019-2027 (USD Billion)
1.2.2. Myasthenia Gravis Treatment Market, by End-Use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Myasthenia Gravis Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Myasthenia Gravis Treatment Market Dynamics
3.1. Myasthenia Gravis Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness for the autoimmune diseases
3.1.1.2. Growth of biologics and biosimilars industry
3.1.2. Market Challenges
3.1.2.1. Lack of awareness for Myasthenia Gravis disease
3.1.3. Market Opportunities
3.1.3.1. Growing research in causes and treatment of Myasthenia Gravis
Chapter 4. Global Myasthenia Gravis Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Myasthenia Gravis Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Myasthenia Gravis Treatment Market by Treatment, Performance - Potential Analysis
5.3. Global Myasthenia Gravis Treatment Market Estimates & Forecasts by Treatment 2018-2027 (USD Billion)
5.4. Myasthenia Gravis Treatment Market, Sub Segment Analysis
5.4.1. Medication Market
5.4.2. Surgery Market
5.4.3. Others Market
Chapter 6. Global Myasthenia Gravis Treatment Market, by End-Use
6.1. Market Snapshot
6.2. Global Myasthenia Gravis Treatment Market by End-Use, Performance - Potential Analysis
6.3. Global Myasthenia Gravis Treatment Market Estimates & Forecasts by End-Use 2018-2027 (USD Billion)
6.4. Myasthenia Gravis Treatment Market, Sub Segment Analysis
6.4.1. Hospitals Market
6.4.2. Clinics Market
6.4.3. Others Market
Chapter 7. Global Myasthenia Gravis Treatment Market, Regional Analysis
7.1. Myasthenia Gravis Treatment Market, Regional Market Snapshot
7.2. North America Myasthenia Gravis Treatment Market
7.2.1. U.S. Myasthenia Gravis Treatment Market
7.2.1.1. Treatment breakdown estimates & forecasts, 2018-2027
7.2.1.2. End-Use breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Myasthenia Gravis Treatment Market
7.3. Europe Myasthenia Gravis Treatment Market Snapshot
7.3.1. U.K. Myasthenia Gravis Treatment Market
7.3.2. Germany Myasthenia Gravis Treatment Market
7.3.3. France Myasthenia Gravis Treatment Market
7.3.4. Spain Myasthenia Gravis Treatment Market
7.3.5. Italy Myasthenia Gravis Treatment Market
7.3.6. Rest of Europe Myasthenia Gravis Treatment Market
7.4. Asia-Pacific Myasthenia Gravis Treatment Market Snapshot
7.4.1. China Myasthenia Gravis Treatment Market
7.4.2. India Myasthenia Gravis Treatment Market
7.4.3. Japan Myasthenia Gravis Treatment Market
7.4.4. Australia Myasthenia Gravis Treatment Market
7.4.5. South Korea Myasthenia Gravis Treatment Market
7.4.6. Rest of Asia Pacific Myasthenia Gravis Treatment Market
7.5. Latin America Myasthenia Gravis Treatment Market Snapshot
7.5.1. Brazil Myasthenia Gravis Treatment Market
7.5.2. Mexico Myasthenia Gravis Treatment Market
7.6. Rest of The World Myasthenia Gravis Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.3. Alexion Pharmaceutical Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Grifols SA
8.3.3. Avadel Pharmaceuticals, Plc.
8.3.4. Novartis
8.3.5. Pfizer, Inc.
8.3.6. AbbVie Inc.
8.3.7. F.Hoffmann-La Roche AG
8.3.8. GlaxoSmithKline Plc.
8.3.9. Bausch Health Companies Inc.
8.3.10. Shire plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption



List of Figures


List of figures
FIG 1. Global Myasthenia Gravis Treatment Market, research methodology
FIG 2. Global Myasthenia Gravis Treatment Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Myasthenia Gravis Treatment Market, key trends 2020
FIG 5. Global Myasthenia Gravis Treatment Market, growth prospects 2021-2027
FIG 6. Global Myasthenia Gravis Treatment Market, porters 5 force model
FIG 7. Global Myasthenia Gravis Treatment Market, pest analysis
FIG 8. Global Myasthenia Gravis Treatment Market, value chain analysis
FIG 9. Global Myasthenia Gravis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Myasthenia Gravis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Myasthenia Gravis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Myasthenia Gravis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Myasthenia Gravis Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Myasthenia Gravis Treatment Market, regional snapshot 2018 & 2027
FIG 15. North America Myasthenia Gravis Treatment Market 2018 & 2027 (USD Billion)
FIG 16. Europe Myasthenia Gravis Treatment Market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Myasthenia Gravis Treatment Market 2018 & 2027 (USD Billion)
FIG 18. Latin America Myasthenia Gravis Treatment Market 2018 & 2027 (USD Billion)
FIG 19. Global Myasthenia Gravis Treatment Market, company market share analysis (2020)


List of Tables


List of Tables
TABLE 1. Global Myasthenia Gravis Treatment Market, report scope
TABLE 2. Global Myasthenia Gravis Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Myasthenia Gravis Treatment Market estimates & forecasts by Treatment 2018-2027 (USD Billion)
TABLE 4. Global Myasthenia Gravis Treatment Market estimates & forecasts by End-Use 2018-2027 (USD Billion)
TABLE 5. Global Myasthenia Gravis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Myasthenia Gravis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Myasthenia Gravis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Myasthenia Gravis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Myasthenia Gravis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Myasthenia Gravis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Myasthenia Gravis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Myasthenia Gravis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Myasthenia Gravis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Myasthenia Gravis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. U.S. Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 17. U.S. Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. Canada Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Canada Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 20. Canada Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. UK Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. UK Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. UK Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Germany Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Germany Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Germany Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. RoE Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. RoE Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. RoE Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. China Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. China Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. China Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. India Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. India Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. India Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Japan Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Japan Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Japan Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. RoAPAC Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. RoAPAC Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. RoAPAC Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Brazil Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. Brazil Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. Brazil Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Mexico Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. Mexico Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. Mexico Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. RoLA Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. RoLA Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. RoLA Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Row Myasthenia Gravis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Row Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Row Myasthenia Gravis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Myasthenia Gravis Treatment Market
TABLE 55. List of primary sources, used in the study of global Myasthenia Gravis Treatment Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered